January 3, 2018 / 2:11 PM / 6 months ago

BRIEF-Ligand Earns $6 Million As Omniab Partner Out-Licenses Antibody Projects

Jan 3 (Reuters) - Ligand Pharmaceuticals Inc:

* LIGAND EARNS $6 MILLION AS OMNIAB PARTNER OUT-LICENSES ANTIBODY PROJECTS

* SEES FY 2017 ADJUSTED EARNINGS PER SHARE $3.13 TO $3.16

* SEES FY 2017 REVENUE ABOUT $140 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below